Fortress Biotech, Inc.
FBIO
$2.76
$0.072.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 108.22% | 63.80% | 24.49% | 24.14% | 38.05% |
| Total Depreciation and Amortization | 2.16% | -7.05% | -6.04% | -25.56% | -33.90% |
| Total Amortization of Deferred Charges | -39.66% | -43.28% | -41.94% | -32.26% | -26.77% |
| Total Other Non-Cash Items | -40.40% | -18.54% | 55.29% | 49.16% | 49.69% |
| Change in Net Operating Assets | 2.55% | 9.33% | -29.02% | 35.08% | -409.12% |
| Cash from Operations | 35.30% | 19.05% | 32.63% | 37.46% | 27.57% |
| Capital Expenditure | -- | -- | -- | -- | 77.78% |
| Sale of Property, Plant, and Equipment | -- | -80.58% | -80.58% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -42,757.14% | -1,349.28% | -393.42% | -86.57% | 99.58% |
| Cash from Investing | -7,644.44% | -256.99% | -577.56% | -613.27% | 97.41% |
| Total Debt Issued | -90.60% | 98.01% | 200.57% | 2.68% | 61.20% |
| Total Debt Repaid | -158.43% | 82.81% | 96.55% | 98.48% | 99.38% |
| Issuance of Common Stock | -86.32% | -56.00% | -45.17% | -10.38% | 89.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 33.75% | 33.75% | 62.50% | -- | -370.59% |
| Total Dividends Paid | 100.00% | 100.00% | 75.00% | 50.00% | 24.99% |
| Other Financing Activities | 691.30% | -35.37% | -33.14% | -82.17% | -78.59% |
| Cash from Financing | 10.27% | 2.56% | 147.13% | 115.77% | 1,042.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 291.79% | 75.72% | 109.73% | 74.84% | 89.82% |